China · Delayed Price · Currency is CNY Tat Ka Wai Hong Pharmaceutical Industry Group Company Description
Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. engages in pharmaceutical manufacturing, distribution, retail, and research and development activities in China and Hong Kong.
The company operates retail pharmacy services, including Direct-to-Patient specialty pharmacy operations covering medications for cancer treatment, antiviral therapies, and organ transplant procedures.
It also serves as an emergency pharmaceutical storage provider and public health emergency supply contractor for Hunan Province.
Additionally, the company provides pharmaceutical services, including patient health record management, chronic disease management, and a patient data management system.
It manufactures pharmaceutical products. The company also operates a pharmaceutical wholesaling and distribution business across Hunan Province.
Additionally, it operates a full-time specialized medical institution, conducts pharmaceutical research and development activities, and engages in regenerative medicine operations.
The company offers Chinese patent medicines, chemical pharmaceuticals, medical devices, cleansing and care products, medicinal wines, and food products.
It serves hospitals, medical institutions, institutional pharmacy clients, and individual patients. TAT KA WAI HONG Pharmaceutical Industry Group Co., Ltd. was formerly known as Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd. and changed its name to Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. in September 2026.
Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. was founded in 2002 and is based in Changsha, China.
| Country | China |
| Founded | 2002 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 5,339 |
| CEO | Shengli Hu |
Contact Details
Address: No.30, Fuling Road Changsha, 410000 China | |
| Phone | 86 731 8451 2838 |
| Website | djwk.com.cn |
Stock Details
| Ticker Symbol | 301126 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000054V3 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Shengli Hu | GM, Financial Director and Director |
| Shanhu Chen | Director and Deputy GM |
| Qian Jiang | Board Secretary and Director |
| Hao Qin | Accounting Supervisor |